Healx is an AI-powered, patient-inspired technology company, dedicated to helping rare disease patients around the world access life-improving therapies. There are 7,000 known rare diseases that affect 400 million people across the globe but only 5% of those conditions have an approved treatment. Healx uses artificial intelligence (AI) to identify novel treatments for rare diseases from existing compounds and progress them towards patients in need. Their innovative approach means they can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development. Healx was founded in 2014 in Cambridge, UK, by Dr Tim Guilliams, a Biochemical Engineer and tech entrepreneur, and Dr David Brown, co-inventor of Viagra and former Global Head of Drug Discovery at Roche. In 2019, Healx raised $56 million in Series B funding. In 2019, the company was listed in Tech Nation’s Future Fifty cohort and, in 2020, Healx won 5 prizes at the CogX Awards including Grand Jury Prize and Best AI Product and was listed in CB Insights Digital 150. For more information, visit www.healx.io or follow on Twitter and LinkedIn.